Vaccine Delivery Devices Market Size

Vaccine Delivery Devices Market size was valued at USD 5.76 Billion in 2023 and is poised to grow from USD 6.22 Billion in 2024 to USD 11.59 Billion by 2032, growing at a CAGR of 8.07% during the forecast period (2025-2032).

The global vaccine delivery devices market features intense competition among prominent players, including BD (Becton, Dickinson and Company), Gerresheimer AG, West Pharmaceutical Services, Inc., and Schott AG. These industry leaders continually innovate and diversify their product portfolios, offering a wide range of advanced and user-friendly devices such as syringes, auto-injectors, and needle-free injectors. Emphasis on technological advancements, safety, and precision drives this competition, aimed at capturing larger market shares and meeting the growing demand for efficient vaccine administration worldwide. Additionally, collaborations, acquisitions, and strategic partnerships are common strategies employed to enhance global market presence and capitalize on emerging opportunities. 'BD (Becton, Dickinson and Company) - USA', 'Gerresheimer AG - Germany', 'SCHOTT AG - Germany', 'West Pharmaceutical Services, Inc. - USA', 'Terumo Corporation - Japan', 'Vetter Pharma International GmbH - Germany', 'Nipro Corporation - Japan', 'Weigao Group - China', 'Sulzer Ltd. - Switzerland', 'Ypsomed AG - Switzerland', 'Stevanato Group - Italy', 'Catalent, Inc. - USA', 'Ompi (Stevanato Group) - Italy', 'SCHOTT AG - Germany', 'Elcam Medical - Israel', 'AptarGroup, Inc. - USA', 'Datwyler Group - Switzerland', 'Sandoz International GmbH - Switzerland', 'Ciron Drugs & Pharmaceuticals Pvt. Ltd. - India', 'Shandong Weigao Group Medical Polymer Co., Ltd. - China'

The demand for vaccines has been on the rise due to the ongoing efforts to combat infectious diseases, such as COVID-19 and other preventable illnesses. This demand drives the need for efficient and effective vaccine delivery devices to ensure proper immunization.

Innovations in Needle-Free Delivery Systems: The development and adoption of needle-free vaccine delivery systems were gaining momentum. These systems aim to minimize needle-related anxieties and improve patient compliance by delivering vaccines through alternative methods such as jet injectors, microneedle patches, and nasal sprays. These technologies offer the potential to reduce the risk of needle-stick injuries, improve vaccine stability, and enhance the efficiency of vaccination campaigns.

The largest application segment for activated carbon fibers has historically been air purification. With increasing concerns about indoor air quality and pollution, the demand for air purification systems that utilize activated carbon fibers for effective VOC and odor removal has been on the rise.